These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

465 related articles for article (PubMed ID: 24525562)

  • 21. Substrate-dependent modulation of UDP-glucuronosyltransferase 1A1 (UGT1A1) by propofol in recombinant human UGT1A1 and human liver microsomes.
    Mano Y; Usui T; Kamimura H
    Basic Clin Pharmacol Toxicol; 2007 Sep; 101(3):211-4. PubMed ID: 17697043
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Influence of mutations associated with Gilbert and Crigler-Najjar type II syndromes on the glucuronidation kinetics of bilirubin and other UDP-glucuronosyltransferase 1A substrates.
    Udomuksorn W; Elliot DJ; Lewis BC; Mackenzie PI; Yoovathaworn K; Miners JO
    Pharmacogenet Genomics; 2007 Dec; 17(12):1017-29. PubMed ID: 18004206
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Influence of uridine diphosphoglucuronic acid on bilirubin glucuronidation in liver microsomes from normal and spironolactone-treated rats.
    Mottino AD; Rodríguez Garay EA
    Acta Physiol Pharmacol Latinoam; 1987; 37(4):479-84. PubMed ID: 3152590
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identification of human UDP-glucuronosyltransferase responsible for the glucuronidation of niflumic acid in human liver.
    Mano Y; Usui T; Kamimura H
    Pharm Res; 2006 Jul; 23(7):1502-8. PubMed ID: 16783480
    [TBL] [Abstract][Full Text] [Related]  

  • 25. N-Glucuronidation of the antiepileptic drug retigabine: results from studies with human volunteers, heterologously expressed human UGTs, human liver, kidney, and liver microsomal membranes of Crigler-Najjar type II.
    Borlak J; Gasparic A; Locher M; Schupke H; Hermann R
    Metabolism; 2006 Jun; 55(6):711-21. PubMed ID: 16713428
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Trans-3'-hydroxycotinine O- and N-glucuronidations in human liver microsomes.
    Yamanaka H; Nakajima M; Katoh M; Kanoh A; Tamura O; Ishibashi H; Yokoi T
    Drug Metab Dispos; 2005 Jan; 33(1):23-30. PubMed ID: 15470160
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In Vitro Evaluation of the Effect of 7-Methyl Substitution on Glucuronidation of Daphnetin: Metabolic Stability, Isoform Selectivity, and Bioactivity Analysis.
    Liang SC; Ge GB; Xia YL; Zhang JW; Qi XY; Tu CX; Yang L
    J Pharm Sci; 2015 Oct; 104(10):3557-64. PubMed ID: 26104686
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Metabolism of the c-Fos/activator protein-1 inhibitor T-5224 by multiple human UDP-glucuronosyltransferase isoforms.
    Uchihashi S; Fukumoto H; Onoda M; Hayakawa H; Ikushiro S; Sakaki T
    Drug Metab Dispos; 2011 May; 39(5):803-13. PubMed ID: 21346002
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Raloxifene glucuronidation in liver and intestinal microsomes of humans and monkeys: contribution of UGT1A1, UGT1A8 and UGT1A9.
    Kishi N; Takasuka A; Kokawa Y; Isobe T; Taguchi M; Shigeyama M; Murata M; Suno M; Hanioka N
    Xenobiotica; 2016; 46(4):289-95. PubMed ID: 26247833
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identification and characterization of human UDP-glucuronosyltransferases responsible for the in vitro glucuronidation of bergenin.
    Song H; Wang J; Zhang R; Liu X; Yuan G; Wei C; Wang B; Guo R
    Biomed Chromatogr; 2014 Mar; 28(3):348-53. PubMed ID: 23996546
    [TBL] [Abstract][Full Text] [Related]  

  • 31. UDP-glucuronosyltransferase 1A1 is the principal enzyme responsible for puerarin metabolism in human liver microsomes.
    Luo CF; Cai B; Hou N; Yuan M; Liu SM; Ji H; Xiong LG; Xiong W; Luo JD; Chen MS
    Arch Toxicol; 2012 Nov; 86(11):1681-90. PubMed ID: 22648071
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The "albumin effect" and drug glucuronidation: bovine serum albumin and fatty acid-free human serum albumin enhance the glucuronidation of UDP-glucuronosyltransferase (UGT) 1A9 substrates but not UGT1A1 and UGT1A6 activities.
    Rowland A; Knights KM; Mackenzie PI; Miners JO
    Drug Metab Dispos; 2008 Jun; 36(6):1056-62. PubMed ID: 18362158
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Atypical Kinetics and Albumin Effect of Glucuronidation of 5-n-Butyl-4-{4-[2-(1H-tetrazole-5- yl)-1H-pyrrol-1-yl]phenylmethyl}-2,4-dihydro-2-(2,6- dichlorophenyl)-3H-1,2,4-triazol-3-one, a Novel Nonpeptide Angiotensin Type 1 Receptor Antagonist, in Liver Microsomes and UDP-Glucuronosyl-transferase.
    Peng Y; Zhang X; Zhu Y; Wu H; Gu S; Chang Q; Zhou Y; Wang G; Sun J
    Molecules; 2018 Mar; 23(3):. PubMed ID: 29562678
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In vitro glucuronidation of thyroxine and triiodothyronine by liver microsomes and recombinant human UDP-glucuronosyltransferases.
    Tong Z; Li H; Goljer I; McConnell O; Chandrasekaran A
    Drug Metab Dispos; 2007 Dec; 35(12):2203-10. PubMed ID: 17875670
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluation of bisphenol A glucuronidation according to UGT1A1*28 polymorphism by a new LC-MS/MS assay.
    Trdan Lušin T; Roškar R; Mrhar A
    Toxicology; 2012 Feb; 292(1):33-41. PubMed ID: 22154984
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Resveratrol (trans-resveratrol, 3,5,4'-trihydroxy-trans-stilbene) glucuronidation exhibits atypical enzyme kinetics in various protein sources.
    Iwuchukwu OF; Nagar S
    Drug Metab Dispos; 2008 Feb; 36(2):322-30. PubMed ID: 17991766
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Involvement of human hepatic UGT1A1, UGT2B4, and UGT2B7 in the glucuronidation of carvedilol.
    Ohno A; Saito Y; Hanioka N; Jinno H; Saeki M; Ando M; Ozawa S; Sawada J
    Drug Metab Dispos; 2004 Feb; 32(2):235-9. PubMed ID: 14744946
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In vitro glucuronidation using human liver microsomes and the pore-forming peptide alamethicin.
    Fisher MB; Campanale K; Ackermann BL; VandenBranden M; Wrighton SA
    Drug Metab Dispos; 2000 May; 28(5):560-6. PubMed ID: 10772635
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Raloxifene glucuronidation in human intestine, kidney, and liver microsomes and in human liver microsomes genotyped for the UGT1A1*28 polymorphism.
    Trdan Lusin T; Trontelj J; Mrhar A
    Drug Metab Dispos; 2011 Dec; 39(12):2347-54. PubMed ID: 21937736
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hepatic glucuronidation of tetrabromobisphenol A and tetrachlorobisphenol A: interspecies differences in humans and laboratory animals and responsible UDP-glucuronosyltransferase isoforms in humans.
    Hanioka N; Isobe T; Saito K; Nagaoka K; Mori Y; Jinno H; Ohkawara S; Tanaka-Kagawa T
    Arch Toxicol; 2024 Mar; 98(3):837-848. PubMed ID: 38182911
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.